UBS Maintains Neutral on Nuveen Churchill Direct, Lowers Price Target to $16.25
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
UBS analyst Vilas Abraham maintains Nuveen Churchill Direct (NYSE:NCDL) with a Neutral and lowers the price target from $18 to $16.25.
UBS analyst Vilas Abraham maintains Nuveen Churchill Direct (NYSE:NCDL) with a Neutral and lowers the price target from $18 to $16.25.